top of page
Search Results

562 items found for "Montana Molecular"

Posts (236)

  • Molecular insights into psychedelic drug action

    such applications, however, is a clearer understanding of how these drugs exert their effects at the molecular Here we review the current knowledge regarding the molecular details of psychedelic drug actions and

  • Molecular targets of psychedelic-induced plasticity

    August 2022 "Psychedelic research across different disciplines and biological levels is growing at a remarkably fast pace. In the prospect of a psychedelic drug becoming again an approved treatment, much of these efforts have been oriented toward exploring the relationship between the actual psychedelic effects and those manifestations of therapeutic interest. Considering the central role of the serotonin 5-HT2A receptor in the distinct effects of psychedelics in human psyche, neuropharmacology sits at the center of this debate and exploratory continuum. Here we discuss some of the most recent findings in human studies and contextualize them considering previous preclinical models studying phenomena related to synaptic plasticity. A special emphasis is placed on knowledge gaps, challenges, and limitations to evaluate the underpinnings of psychedelics' potential antidepressant action." Read more at the source #DrGPCR #GPCR #IndustryNews

  • Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1

    Through (un)biased molecular dynamics simulations and mutagenesis experiments, we show that TM2 rearrangement

View All

Other Pages (326)

  • 23-08 Dr GPCR Newsletter

    Therapeutics Terry Kenakin , Professor at the University of North Carolina Sam Hoare , Kinetic Data Analyst at Montana Molecular The symposium is free, but you must be a Dr. Ecosystem Partners We thank Domain Therapeutics , GPCR Therapeutics , Design Pharmaceuticals , Montana Molecular , and Orion Biotechnology for supporting Dr. Drugs, and more GPCRs in Cardiology, Endocrinology, and Taste Reviews, GPCRs, and more Structural and Molecular

  • 23-05 Dr GPCR Newsletter

    Ecosystem Partners We are grateful to Domain Therapeutics , GPCR Therapeutics , Design Pharmaceuticals , Montana Molecular as well as the newest addition to our Ecosystem Orion Biotechnology for supporting Dr. Drugs, and more GPCRs in Cardiology, Endocrinology, and Taste Reviews, GPCRs, and more Structural and Molecular

  • News | Dr. GPCR Ecosystem

    /24 Orphan GPCR GPRC5C Facilitates Angiotensin II-Induced Smooth Muscle Contraction Details 4/10/24 Molecular consequences on G protein signalling Details 4/9/24 Exploring GPCR conformational dynamics using single-molecule receptor Details 4/8/24 High incidence of imperforate vagina in ADGRA3-deficient mice Details 4/8/24 Montana Molecular is joining the BioTools Innovator program Details Contribute to the GPCR News -Coming soon and more GPCR Industry News GPCRs in Neuroscience Methods & Updates in GPCR Research Structural and molecular

View All
bottom of page